KKR slips 5.1% as private-credit concerns spill over from affiliated lender results

KKR & Co. Inc. (KKR) is down 5.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to renewed investor anxiety around private-credit asset quality and dividend sustainability in publicly traded lending vehicles associated with KKR. Recent turbulence around an affiliated business development company’s portfolio performance and payout reset has likely kept sentiment fragile across alternative-asset managers.

Details:

A publicly traded private-credit vehicle co-managed with KKR announced a lower quarterly distribution and discussed pressure from weaker investment income and credit issues, bringing more scrutiny to the broader direct-lending complex.

That vehicle’s shares sold off sharply in late February after it highlighted a rise in troubled loans and portfolio marks, adding to worries about the credit cycle for middle-market borrowers.

Even though KKR is an asset manager (not a lender balance sheet in the same way), the market often trades the stock on expectations for fee growth, fundraising durability, and realizations—all of which can be questioned when credit stress headlines intensify.

Separately, a KKR co-CEO disclosed an open-market purchase of KKR shares in late February, which may be interpreted as a confidence signal but did not prevent continued near-term volatility.

Sources:

PR Newswire, LiveMint, U.S. SEC (Form 4)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$KKR Insider Trading Activity

$KKR insiders have traded $KKR stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KKR stock by insiders over the last 6 months:

SCOTT C NUTTALL (Co-Chief Executive Officer) has made 3 purchases buying 125,000 shares for an estimated $12,833,087 and 0 sales.
JOSEPH Y BAE (Co-Chief Executive Officer) has made 4 purchases buying 125,000 shares for an estimated $12,773,530 and 0 sales.
TIMOTHY R BARAKETT has made 2 purchases buying 100,000 shares for an estimated $9,970,000 and 0 sales.
MATT COHLER purchased 43,872 shares for an estimated $4,514,428

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$KKR Hedge Fund Activity

We have seen 630 institutional investors add shares of $KKR stock to their portfolio, and 718 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 10,010,829 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $1,276,180,480
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 5,879,512 shares (+7554.7%) to their portfolio in Q4 2025, for an estimated $749,520,189
CAPITAL INTERNATIONAL INVESTORS added 5,832,705 shares (+18.6%) to their portfolio in Q4 2025, for an estimated $743,553,233
CAPITAL WORLD INVESTORS removed 4,130,462 shares (-38.6%) from their portfolio in Q4 2025, for an estimated $526,551,295
STRIVE ASSET MANAGEMENT, LLC added 4,123,951 shares (+inf%) to their portfolio in Q3 2025, for an estimated $535,907,432
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,163,915 shares (-60.4%) from their portfolio in Q4 2025, for an estimated $403,335,884
WELLINGTON MANAGEMENT GROUP LLP added 2,949,378 shares (+12.3%) to their portfolio in Q4 2025, for an estimated $375,986,707

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$KKR Government Contracts

We have seen $91,496 of award payments to $KKR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

BIOSEARCH TECHNOLOGIES - PRIMERS AND PROBES: $51,128

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$KKR Congressional Stock Trading

Members of Congress have traded $KKR stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $KKR stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 11/19.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 10/17 and 1 sale worth up to $15,000 on 11/07.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$KKR Analyst Ratings

Wall Street analysts have issued reports on $KKR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

TD Cowen issued a "Buy" rating on 11/10/2025
Morgan Stanley issued a "Overweight" rating on 10/21/2025
Oppenheimer issued a "Outperform" rating on 10/14/2025

To track analyst ratings and price targets for $KKR, check out Quiver Quantitative's $KKR forecast page.

$KKR Price Targets

Multiple analysts have issued price targets for $KKR recently. We have seen 8 analysts offer price targets for $KKR in the last 6 months, with a median target of $142.5.

Here are some recent targets:

Benjamin Budish from Barclays set a target price of $127.0 on 03/02/2026
Bart Dziarski from RBC Capital set a target price of $137.0 on 02/24/2026
Michael Brown from UBS set a target price of $125.0 on 02/20/2026
Chris Kotowski from Oppenheimer set a target price of $187.0 on 02/06/2026
Bill Katz from TD Cowen set a target price of $131.0 on 01/14/2026
Michael Cyprys from Morgan Stanley set a target price of $166.0 on 10/21/2025
Christopher Allen from Citigroup set a target price of $150.0 on 10/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.